Tennessee Senate Bill 2499
Session 114
TennCare - As introduced, requires a managed care organization or pharmacy benefits manager that is contracted with the bureau to reimburse a claim for a long-acting injectable drug intended for treatment and prevention of human immunodeficiency virus and administered in a pharmacy, physician's office, clinic, ambulatory surgical treatment center, or hospital. - Amends TCA Title 4; Title 56 and Title 71.
Active
Passed House on Mar 5, 2026
Origin Chamber
Senate
Type
Bill
Bill Number
2499
State
Tennessee
Session
114
Senate votes are unavailable for this bill.
Summary
Unavailable
Current Version
Sort by most recent
03/05/2026
House
Passed on Second Consideration, refer to Senate Commerce and Labor Committee
03/04/2026
House
Placed on Senate Commerce and Labor Committee calendar for 3/10/2026
03/02/2026
House
Approved by Delayed Bills Committee
03/02/2026
House
Introduced, Passed on First Consideration
02/02/2026
House
Filed for introduction
02/02/2026
House
Refer to Senate Delayed Bills Committee
Sources
Open States
Record Created
Mar 4, 2026 10:45:40 PM
Record Updated
Mar 4, 2026 10:45:40 PM